Orphazyme
DenmarkEntry
2017
Hold
9yr
Status
Active
Who owns Orphazyme?
Orphazyme is currently owned by Eurazeo through Kurma Biofund III (2017 vintage), since 2017. Across its history, Orphazyme has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
EurazeoKurma Biofund III · 2017 · Healthcare
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods
Active
Sunstone Life Science VenturesExited 2017
2011 · 2017(6yr) · Sunstone Life Science Ventures III · 2007 · VC
IPO
MOIC
–
EurazeoActive
2017 · present(9yr) · Kurma Biofund III · 2017 · Healthcare
More from Kurma Biofund III
Other portfolio companies in the same fund.
France
Netherlands
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Orphazyme
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Orphazyme?
1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Orphazyme.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue